Global: number of Glaxosmithkline patent filings by legal status 1998-2018| ��ƽ��

Number of Glaxosmithkline patent families* worldwide by filing year from 1998 to 2018, by legal status

Filing Year	In force**	Pending	Inactive
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-
-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

In cooperation with

Release date

February 2020

More information

Region

Worldwide

Survey time period

February 6, 2019

Supplementary notes

* A patent family is defined as a group of patent documents all of which have the same set of priorities. I.e., it is a group of patent documents that protect the same invention across authorities.

** The 'In force' category covers patent families that have been granted and are active.

*** As it usually takes 18 months after first filing for a patent to get published, the data for the year 2018 is subject to change.

The owner of a patent includes all patents owned by a company and its subsidiaries (by at least 50%) based on comprehensive research on corporate structures, M&A, Spin-offs, company names changes, patent transactions. PatentSight also tracks former names of companies and subsidiaries, ongoing mergers and acquisitions, acquisitions of the past, reassignments, companies that have the same applicant, and transliterations by patent offices.

Citation formats

Glaxosmithkline filed the largest number of patents in the year 2000 with filings. Since then the company's filings have decreased noticeably. and reached a low of *** filings in 2014, before increasing slightly in recent years. The timeline is based on data provided by.
Glaxosmithkline was founded in 2000 with the merger of Galaxo Wellcome and SmithKline Beecham. The London based company is one of the ten biggest pharmaceutical companies in the world.